Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 46 studies | 43% ± 18% | |
pericyte | 27 studies | 37% ± 14% | |
smooth muscle cell | 23 studies | 37% ± 18% | |
endothelial cell of lymphatic vessel | 17 studies | 33% ± 11% | |
fibroblast | 14 studies | 38% ± 17% | |
astrocyte | 13 studies | 33% ± 15% | |
endothelial cell of artery | 13 studies | 37% ± 12% | |
endothelial cell of vascular tree | 11 studies | 35% ± 16% | |
vein endothelial cell | 11 studies | 41% ± 16% | |
mesothelial cell | 11 studies | 45% ± 14% | |
capillary endothelial cell | 10 studies | 28% ± 14% | |
epithelial cell | 9 studies | 36% ± 16% | |
adipocyte | 8 studies | 38% ± 17% | |
glutamatergic neuron | 7 studies | 34% ± 17% | |
ciliated cell | 7 studies | 27% ± 9% | |
GABAergic neuron | 6 studies | 25% ± 12% | |
oligodendrocyte precursor cell | 6 studies | 23% ± 7% | |
myofibroblast cell | 6 studies | 23% ± 10% | |
type II pneumocyte | 6 studies | 24% ± 5% | |
retinal rod cell | 5 studies | 30% ± 10% | |
basal cell | 5 studies | 41% ± 22% | |
kidney loop of Henle epithelial cell | 4 studies | 29% ± 6% | |
retinal pigment epithelial cell | 4 studies | 45% ± 13% | |
cardiac muscle cell | 4 studies | 22% ± 4% | |
lymphocyte | 4 studies | 21% ± 2% | |
muscle cell | 4 studies | 38% ± 8% | |
club cell | 4 studies | 35% ± 10% | |
myoepithelial cell | 4 studies | 31% ± 17% | |
cholangiocyte | 3 studies | 42% ± 14% | |
hepatic stellate cell | 3 studies | 37% ± 8% | |
glomerular endothelial cell | 3 studies | 22% ± 4% | |
neuron | 3 studies | 32% ± 5% | |
macrophage | 3 studies | 28% ± 6% | |
placental villous trophoblast | 3 studies | 36% ± 25% | |
endocardial cell | 3 studies | 44% ± 12% | |
GABAergic amacrine cell | 3 studies | 29% ± 7% | |
endothelial cell of sinusoid | 3 studies | 35% ± 10% | |
goblet cell | 3 studies | 19% ± 5% | |
transit amplifying cell | 3 studies | 42% ± 35% | |
interneuron | 3 studies | 45% ± 14% | |
parietal epithelial cell | 3 studies | 68% ± 5% | |
podocyte | 3 studies | 84% ± 3% | |
renal alpha-intercalated cell | 3 studies | 25% ± 5% | |
renal principal cell | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 9399.09 | 89 / 89 | 99% | 129.86 | 888 / 901 |
breast | 100% | 16989.15 | 459 / 459 | 96% | 60.66 | 1068 / 1118 |
lung | 99% | 13579.49 | 575 / 578 | 95% | 38.87 | 1101 / 1155 |
intestine | 96% | 6660.57 | 928 / 966 | 98% | 40.31 | 516 / 527 |
bladder | 100% | 6973.62 | 21 / 21 | 93% | 36.04 | 470 / 504 |
thymus | 99% | 7295.89 | 644 / 653 | 95% | 45.48 | 572 / 605 |
ovary | 97% | 6057.64 | 174 / 180 | 93% | 26.60 | 399 / 430 |
esophagus | 88% | 7358.45 | 1277 / 1445 | 99% | 39.12 | 181 / 183 |
prostate | 87% | 5257.62 | 214 / 245 | 93% | 34.04 | 467 / 502 |
uterus | 97% | 7605.59 | 165 / 170 | 80% | 27.97 | 368 / 459 |
brain | 64% | 2762.62 | 1702 / 2642 | 95% | 29.95 | 668 / 705 |
stomach | 53% | 3424.43 | 191 / 359 | 96% | 40.15 | 274 / 286 |
skin | 99% | 17570.76 | 1787 / 1809 | 45% | 11.39 | 212 / 472 |
pancreas | 14% | 479.51 | 46 / 328 | 97% | 43.17 | 172 / 178 |
adipose | 100% | 20857.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 31043.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.72 | 1 / 1 |
adrenal gland | 41% | 1476.22 | 107 / 258 | 56% | 14.29 | 129 / 230 |
muscle | 96% | 8051.29 | 768 / 803 | 0% | 0 | 0 / 0 |
spleen | 93% | 5566.85 | 224 / 241 | 0% | 0 | 0 / 0 |
heart | 74% | 3636.52 | 639 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 19.24 | 33 / 45 |
liver | 8% | 303.81 | 18 / 226 | 53% | 21.42 | 214 / 406 |
lymph node | 0% | 0 | 0 / 0 | 45% | 7.39 | 13 / 29 |
eye | 0% | 0 | 0 / 0 | 21% | 4.33 | 17 / 80 |
peripheral blood | 8% | 371.96 | 73 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0007399 | Biological process | nervous system development |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005010 | Molecular function | insulin-like growth factor receptor activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
Gene name | CRIM1 |
Protein name | Cysteine-rich motor neuron 1 protein Cysteine rich transmembrane BMP regulator 1 Uncharacterized protein CRIM1 Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein] |
Synonyms | UNQ1886/PRO4330 S52 |
Description | FUNCTION: May play a role in CNS development by interacting with growth factors implicated in motor neuron differentiation and survival. May play a role in capillary formation and maintenance during angiogenesis. Modulates BMP activity by affecting its processing and delivery to the cell surface. . |
Accessions | ENST00000619072.1 H7C1Z0 ENST00000619935.1 A0A0G2JN95 ENST00000413985.1 ENST00000428774.1 ENST00000426856.1 Q53TH9 H7C458 ENST00000613124.1 A0A0G2JN98 H7C2T6 Q4ZG85 ENST00000280527.7 Q9NZV1 Q53TR0 |